z-logo
open-access-imgOpen Access
No Evidence of Viral Coinfection in Cerebrospinal Fluid From Patients With Community-Acquired Bacterial Meningitis
Author(s) -
Matthijs C. Brouwer,
Kin Ki Jim,
Kimberley Benschop,
Katja C. Wolthers,
Arie van der Ende,
Menno D. de Jong,
Diederik van de Beek
Publication year - 2013
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jit140
Subject(s) - coinfection , cerebrospinal fluid , viral meningitis , bacterial meningitis , meningitis , virology , medicine , microbiology and biotechnology , immunology , biology , pathology , virus , pediatrics
TO THE EDITOR—Bacterial meningitis is a severe disease with substantial mortality and morbidity despite the availability of effective antimicrobial agents and adjunctive therapies [1, 2]. Recently, a study involving adults with community-acquired bacterial meningitis in Malawi showed that coinfection with Epstein Barr Virus (EBV) occurred in 79 of 149 bacterial meningitis patients (53%) and that EBV load was associated with higher mortality [3]. Coinfection with cytomegalovirus (CMV) was detected in 7% of patients. A high proportion of patients (77%) in this study were human immunodeficiency virus (HIV) positive, which was found to have a strong influence on the rate of coinfection with EBV and CMV. The aim of the current study was to establish whether herpes viruses and other neurotropic viruses could be detected in the cerebrospinal fluid (CSF) of adult bacterial meningitis patients in a Dutch population with a low HIV infection rate. We analyzed CSF samples from a random subset of bacterial meningitis patients included in a nationwide prospective cohort [4]. Patients were included if they had community-acquired bacterial meningitis confirmed by CSF culture or if CSF results showed at least 1 individual predictor of bacterial meningitis, defined as a glucose level of <34 mg/ dL, a ratio of CSF glucose to blood glucose of <0.23, a protein level of >220 mg/dL, or a leukocyte count of >2000 cells/μL [5]. Informed consent was obtained from all participating patients or their legally authorized representatives. CSF was stored locally at −80°C, after which it was brought to the Academic Medical Center (Amsterdam, the Netherlands), where samples were thawed once, spun down, aliquoted, and again stored at −80°C until analysis. Nucleic acid was extracted by automated extraction (MagnaPure, Roche Diagnostics), and reverse transcription using random hexamers was performed. Five microliters of reverse transcription reaction was subsequently used to detect EBV, CMV, herpes simplex virus 1 and 2, varicellazoster virus, adenovirus, enterovirus, human parechovirus, and human herpesvirus types 6 and 7 simultaneously in an internally controlled 4-tube real-time multiplex assay. CSF was available for 204 of 642 bacterial meningitis patients (27%) included in the cohort [4]. Polymerase chain reaction (PCR) was performed on 56 random CSF samples, derived from the diagnostic lumbar puncture. Most of these 56 patients had classical symptoms and signs of bacterial meningitis, and CSF examination showed at least 1 individual predictor of bacterial meningitis in 49 patients (88%; Table 1) [5]. Causative bacteria were identified by CSF culture in 51 patients, which yielded Streptococcus pneumonia in CSF from 42 patients (72%), Neisseria meningitidis in CSF from 3 (5%), Haemophilus influenza in CSF from 2 (4%), and Staphylococcus aureus, Streptococcus oralis, and Streptococcus agalactiae each in CSF from 1 (2%). In 5 patients with negative results of CSF cultures, blood culture showed S. pneumoniae in 2 and N. meningitidis and S. agalactiae each in 1. All patients with negative results of CSF cultures had at least 1 individual CSF predictor of bacterial meningitis [5]. During the course of illness, 5 patients (9%) developed herpes simplex stomatitis, and 1 (4%) developed herpes zoster. Real-time PCR was

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom